Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States

Hepatology

Volumn 62, Issue 5, 2015, Pages 1339-1341

  Gish, Robert G ^a,b,c,d   Cohen, Chari A ^b   Block, Joan M ^b   Brosgart, Carol L ^e   Block, Timothy M ^b,f,g   Clary, Ryan ^c   Le, Loc T ^h   Ninburg, Michael H ^c,i   Sandt, Lorren ^j   Kowdley, Kris V ^k  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEPATITIS B FOUNDATION   (United States)

^c National Viral Hepatitis Roundtable   (United States)

^d The FAIR Foundation   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BARUCH S BLUMBERG INSTITUTE   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h National Task Force on Hepatitis B   (United States)

ⁱ Hepatitis Education Project   (United States)

^j Caring Ambassadors Program   (United States)

^k SWEDISH MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; HEALTH CARE COST; HOMELESSNESS; HUMAN; INFECTION RISK; MENTAL DISEASE; PACIFIC ISLANDER; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SUBSTANCE ABUSE; UNITED STATES; FEMALE; HEPATITIS C; MALE;

FEMALE; HEPATITIS C; HUMANS; MALE;

EID: 84945219388     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28026     Document Type: Article

References (19)

1. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57:1-20.
2. Denniston MM, Jiles RB, Drobeniuc J, Klevens M, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
3. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422-433.
4. Cohen C, Evans AA, London WT, Block J, Conti M, Block T. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat 2008;15:12-13.
5. Decker MD, Vaughn WK, Brodie JS, Hutcheson RH Jr, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis 1984;150:450-459.
6. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004;81:25-37.
7. Weinbaum C, Lyerla R, Margolis HS; Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep 2003;52:1-36; quiz CE31-CE34.
8. Mumola CJ. Substance abuse and treatment, state and federal prisoners, 1997. Washington, DC: Bureau of Justice Statistics; 1999.
9. National Institute on Drug Abuse. Prevalence of drug use in the Washington, DC, metropolitan area homeless and transient population: 1991. Rockville, MD; 1991.
10. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry 2003;44:293-302.
11. Varan A, Mercer D, Stein MS, Spaulding AC. State prison system surveillance of hepatitis C exposure: limited data show declining share of US epidemic. Presented at: Fifth Academic and Health Policy Conference on Correctional Health; March 22-23, 2012; Atlanta, GA.
12. National Center for Infectious Diseases. National hepatitis C prevention strategy: a comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences. Bethesda, MD: Centers for Disease Control and Prevention; 2001.
13. Strehlow AJ, Robertson MJ, Zerger S, Rongey C, Arangua L, Farrell E, et al. Hepatitis C among clients of health care for the homeless primary care clinics. J Health Care Poor Underserved 2012;23:811-833.
14. Edlin BR, Eckhardt B, Shu M, Holmberg S, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology 2015;62:1353-1363.
15. Church D. Hepatitis C surveillance: what does the actual epidemic look like? Presented at: National Summit to Improve Access to HCV Testing, Treatment, and Cure; June 17-18, 2014; Atlanta, GA.
16. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714.
17. Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Lu M, et al. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study. Clin Infect Dis 2013;56:40-50.
18. Mahajan R, Xing J, Liu SJ, Ly KN, Moorman AC, Rupp L, et al. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. Clin Infect Dis 2014;58:1055-1061.
19. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013;368:1859-1861.